Drugs Made In America Acquisition Corp. (DMAA) KPIs and segments
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 16, 2026Market cap $264.62MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Drugs Made In America Acquisition's business
Coming soon
This tab will track the numbers specific to Drugs Made In America Acquisition's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?